Matches in Wikidata for { <http://www.wikidata.org/entity/Q65354284> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q65354284 description "clinical trial" @default.
- Q65354284 description "ensayu clínicu" @default.
- Q65354284 description "klinisch onderzoek" @default.
- Q65354284 description "клінічне випробування" @default.
- Q65354284 description "կլինիկական փորձարկում" @default.
- Q65354284 name "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 name "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 type Item @default.
- Q65354284 label "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 label "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 prefLabel "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 prefLabel "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum" @default.
- Q65354284 P1050 Q65354284-1591404D-C9CC-49A8-9D27-70C7BD291C56 @default.
- Q65354284 P1050 Q65354284-7F94DA55-A6ED-4540-BA6A-CDB4006130B5 @default.
- Q65354284 P1132 Q65354284-595CEB04-5578-4FAC-88C7-A5021D53608F @default.
- Q65354284 P1476 Q65354284-2866C578-D93E-45E0-A362-DEE97C9B56CA @default.
- Q65354284 P17 Q65354284-2BB91386-8E80-4725-A336-FE555EFFE20E @default.
- Q65354284 P17 Q65354284-49501545-0D17-4182-BA86-023523128658 @default.
- Q65354284 P17 Q65354284-8EBEC462-039F-41D3-8125-2D7D44DD13A6 @default.
- Q65354284 P2899 Q65354284-04D3C612-D91C-4239-8353-BF0940FCF00E @default.
- Q65354284 P3098 Q65354284-F2552442-78E6-494A-A89B-180A09ECBA6C @default.
- Q65354284 P31 Q65354284-B241B161-5C19-4553-8C4F-C1D8FF2EE735 @default.
- Q65354284 P580 Q65354284-5DA683A5-AD3E-4567-BC46-D5A095AA71FE @default.
- Q65354284 P582 Q65354284-0CCE44F9-2D80-48E5-82EA-9FAF9592FB1E @default.
- Q65354284 P6099 Q65354284-CB431376-3DCF-4A5E-8444-FA062331B643 @default.
- Q65354284 P8363 Q65354284-593FE013-836B-491D-AD6C-497D328606ED @default.
- Q65354284 P921 Q65354284-C30166F9-D406-4726-8924-CE5E447DEFE4 @default.
- Q65354284 P1050 Q1526459 @default.
- Q65354284 P1050 Q2119633 @default.
- Q65354284 P1132 "+15" @default.
- Q65354284 P1476 "A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients With Pyoderma Gangrenosum" @default.
- Q65354284 P17 Q16 @default.
- Q65354284 P17 Q30 @default.
- Q65354284 P17 Q408 @default.
- Q65354284 P2899 "+18" @default.
- Q65354284 P3098 "NCT02318914" @default.
- Q65354284 P31 Q30612 @default.
- Q65354284 P580 "2014-11-01T00:00:00Z" @default.
- Q65354284 P582 "2016-02-01T00:00:00Z" @default.
- Q65354284 P6099 Q42824827 @default.
- Q65354284 P8363 Q78089383 @default.
- Q65354284 P921 Q55786990 @default.